Where does Galderma Group N make most of its revenue?

International: 57% of revenue by region in fiscal year 2025, followed by USA (43%).

Galderma Group N (GALD.SW) Stock

About Galderma Group N

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epid...

At a glance

International was its largest region in fiscal year 2025, with 57% of revenue.

Figures from company filings.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.